Propranolol inhibits infantile hemangioma by regulating the miR-424/vascular endothelial growth factor-A (VEGFA) axis
暂无分享,去创建一个
Hong-yu Chen | S. Shi | Li Li | Zhenghua Wu | Feng Pan
[1] Yubin Gong,et al. LncRNA-MALAT1 promotes tumorogenesis of infantile hemangioma by competitively binding miR-424 to stimulate MEKK3/NF-κB pathway. , 2019, Life sciences.
[2] Biao Gao,et al. Long non-coding RNA 00152 slicing represses the growth and aggressiveness of hemangioma cell by modulating miR-139-5p. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[3] Zhi-Yao He,et al. Progress in the treatment of infantile hemangioma. , 2019, Annals of translational medicine.
[4] Dongdong Jiang,et al. Propranolol suppresses infantile hemangioma cell proliferation and promotes apoptosis by upregulating miR-125b expression , 2019, Anti-cancer drugs.
[5] T. Ochiya,et al. Development of miRNA‐based therapeutic approaches for cancer patients , 2019, Cancer science.
[6] Yanyan Jiang,et al. MiR-187-3p Enhances Propranolol Sensitivity of Hemangioma Stem Cells. , 2019, Cell structure and function.
[7] Kunmei Liu,et al. Characterization of microRNA expression profiles by deep sequencing of small RNA libraries in leukemia patients from Naxi ethnic , 2019, Translational cancer research.
[8] Ying-bin Liu,et al. MicroRNA‑424 suppresses the proliferation of hemangioma‑derived endothelial cells by targeting VEGFR‑2. , 2018, Molecular medicine reports.
[9] J. Szemraj,et al. Single‐nucleotide polymorphisms of VEGF‐A and VEGFR‐2 genes and risk of infantile hemangioma , 2018, International journal of dermatology.
[10] Guan-feng Yu,et al. Co-suppression of VEGF-A and VEGF-C inhibits development of experimental hemangioma. , 2018, American journal of translational research.
[11] Qiurong Ruan,et al. The expression and function of miR-424 in infantile skin hemangioma and its mechanism , 2017, Scientific Reports.
[12] Yuqiang Li,et al. Mechanisms of Action of MicroRNAs in Infantile Hemangioma Tissue and Vascular Endothelial Cells in Different Periods , 2017, Medical science monitor : international medical journal of experimental and clinical research.
[13] Christine Léauté-Labrèze,et al. Infantile haemangioma , 2017, The Lancet.
[14] I. Papangeli,et al. A PPARγ-dependent miR-424/503-CD40 axis regulates inflammation mediated angiogenesis , 2017, Scientific Reports.
[15] Zhang Yu,et al. When to stop propranolol for infantile hemangioma , 2017, Scientific Reports.
[16] F. Gao,et al. Epigenetic silencing of miR-130a ameliorates hemangioma by targeting tissue factor pathway inhibitor 2 through FAK/PI3K/Rac1/mdm2 signaling. , 2017, International journal of oncology.
[17] W. Mackey. Infantile Hemangioma with a Focus on Airway Hemangioma. , 2016, ORL-head and neck nursing : official journal of the Society of Otorhinolaryngology and Head-Neck Nurses.
[18] P. Li,et al. Propranolol induces regression of hemangioma cells via the down‐regulation of the PI3K/Akt/eNOS/VEGF pathway , 2015, Pediatric blood & cancer.
[19] P. Li,et al. Propranolol represses infantile hemangioma cell growth through the β2-adrenergic receptor in a HIF-1α-dependent manner. , 2015, Oncology reports.
[20] W. Liu,et al. Role of miR-424 on angiogenic potential in human dental pulp cells. , 2014, Journal of endodontics.
[21] Quan Xu,et al. [Establishment of human infancy hemangioma-derived endothelial cell line XPTS-1 and animal model of human infancy hemangioma]. , 2011, Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology.
[22] E. Boscolo,et al. Targeting NF-κB in infantile hemangioma-derived stem cells reduces VEGF-A expression , 2010, Angiogenesis.
[23] E. Boscolo,et al. Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells. , 2010, The New England journal of medicine.